Pacira Pharmaceuticals, Inc. 4
4 · Pacira Pharmaceuticals, Inc. · Filed Jun 7, 2017
Insider Transaction Report
Form 4
Jones James B
SVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2017-06-05$43.32/sh−767$33,227→ 9,813 total
Footnotes (2)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Includes 330 shares of common stock acquired under the issuer's employee stock purchase plan in June 2016.